scorecardresearch
Business Today
Subscribe
Immersives UPSTART ICC World Cup Corporate Petrol-Diesel Weather BT Bazaar
BT Golf BT 500 Zero Mile Samvad - IIM Nagpur BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • zero mile samvad iim nagpur
News
Markets
Stocks
Aarti Drugs Ltd

Feedback
Aarti Drugs Ltd

Aarti Drugs Ltd (AARTIDRUGS) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 86,694
Dec 15, 2023 09:51 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹477.30
₹-2.10 (0.02%)
₹476.9 Low
Today’s Performance
₹484.2 High
₹313.9 Low
52 Week’s Performance
₹645.75 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -0.44%
  • 1 Week -2.29%
  • 1 Month 0.45%
  • 3 Months -20.84%
  • 6 Months 5.47%
  • 1 Year 3.78%
  • 3 Years -14.98%
  • 5 Years 27.89%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.31
  • 52-Week Low (₹) 313.90
  • 52-Week High (₹) 645.75
  • Price-to-Book (X)* 3.67
  • Dividend Yield (%) 0.21
  • Price-to-Earnings (P/E) (X)* 24.64
  • Earnings Per Share (₹) 19.46
  • Sector Price Earning (X)* 32.73
  • Market Cap (₹ Cr.)* 4,439.24
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 1:59 Sudeep Shah From SBI Securities Identifies Two Stocks Poised For Strong Upside Movement!
thumb 3:29 Shri Krishna Janmabhoomi Case: High Court Approves Survey Of Shahi Idgah Complex
thumb 2:07 Listen To SMIFS' Sharad Avasthi's Call On DOMS & India Shelter Finance IPOs Ending On Friday
thumb 2:09 Electrifying Delhi's Commute: Delhi's Got More Electric Buses! Hop On Board For A Greener Commute!
thumb 3:59 Derek O'Brien Suspended After Face-off With RS Chairman! MP Charged With "Ignoble Misconduct"
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Oct 18, 2023 Sell
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 480077
  • Average Price ₹554.70
Oct 18, 2023 PURCHASE
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 480077
  • Average Price ₹554.17
Jul 25, 2023 PURCHASE
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 933060
  • Average Price ₹627.89
Jul 25, 2023 Sell
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 933060
  • Average Price ₹628.40
Jul 24, 2023 Sell
Aarti Drugs Ltd. ,QE SECURITIES
  • Qty 505851
  • Average Price ₹587.73
Jul 24, 2023 Sell
Aarti Drugs Ltd. ,NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 553535
  • Average Price ₹588.59
Jul 24, 2023 PURCHASE
Aarti Drugs Ltd. ,NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 553535
  • Average Price ₹588.25
Jul 24, 2023 Sell
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 643754
  • Average Price ₹576.46
Jul 24, 2023 PURCHASE
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 643754
  • Average Price ₹575.88
Jul 24, 2023 PURCHASE
Aarti Drugs Ltd. ,QE SECURITIES
  • Qty 497273
  • Average Price ₹587.77
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Aarti Drugs Ltd share price previously?
Aarti Drugs Ltd share price was down by 0.02% from the previous closing price of ₹479.40.
Who are peers of Aarti Drugs Ltd?
The peers of Aarti Drugs Ltd are Glaxosmithkline Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Syngene International Ltd, Cipla Ltd, Biocon Ltd, Zydus Lifesciences Ltd, Dr Reddys Laboratories Ltd, Alkem Laboratories Ltd, Torrent Pharmaceuticals Ltd, Aurobindo Pharma Ltd, Ipca Laboratories Ltd, Lupin Ltd, Divis Laboratories Ltd, Gland Pharma Ltd,
Who is/are the promoter/promoters of Aarti Drugs Ltd?
The promotor/promotors of Aarti Drugs Ltd are Prakash M Patil, Rashesh C Gogri, Harshit M Savla, Harit P Shah, Uday M Patil, Narendra Jagannath Salvi, Navin Chapshi Shah, Krishnacharya G Akamanchi, Priti Savla, Ankit Vikram Paleja, Bhaskar Narayan Thorat, Neha Gada.
What has been 52-week high of Aarti Drugs Ltd stocks?
The highest price of Aarti Drugs Ltd stock is ₹645.75 in the last 52-week.
What is the share price of Aarti Drugs Ltd (AARTIDRUGS) today on NSE?
As on Dec 15, 2023, Aarti Drugs Ltd (AARTIDRUGS)’s share price on NSE is Rs 477.3
What is the market cap of Aarti Drugs Ltd (AARTIDRUGS?)
The current market capitalisation of Aarti Drugs Ltd (AARTIDRUGS) is 4,439.24 crores
What is Aarti Drugs Ltd Share symbol?
The symbol of Aarti Drugs Ltd is AARTIDRUGS.
What is the PE ratio of Aarti Drugs Ltd (AARTIDRUGS)?
The current PE ratio of Aarti Drugs Ltd (AARTIDRUGS) is 24.64.
What is the PB ratio of Aarti Drugs Ltd (AARTIDRUGS)?
The current PB ratio of Aarti Drugs Ltd (AARTIDRUGS) is 3.67.
Today’s High & Low share prices of Aarti Drugs Ltd (AARTIDRUGS) on NSE?
Today, the share price of Aarti Drugs Ltd (AARTIDRUGS) on NSE touched a high of Rs 484.2 and a low of Rs 476.9
What price did Aarti Drugs Ltd (AARTIDRUGS) shares open on the NSE today?
On NSE, the share price of Aarti Drugs Ltd (AARTIDRUGS) opened at Rs 481.5
What is the 52-week high of Aarti Drugs Ltd (AARTIDRUGS)?
The 52-week high price of Aarti Drugs Ltd (AARTIDRUGS) is Rs 645.75
What is the 52-week low of Aarti Drugs Ltd (AARTIDRUGS) ?
The 52-week low price of Aarti Drugs Ltd (AARTIDRUGS) is Rs 313.9

ABOUT AARTI DRUGS

Aarti Drugs Ltd, incorporated in the year 1984, has its registered office in Plot No N-198 MIDC Tarapur, Pamtembhi Village Palghar Tal, Thane, Maharashtra, 401506, 91-22-24072249, 91-22-24073462/24070144. The main industry in which Aarti Drugs Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Aarti Drugs Ltd is/are Kirtane & Pandit LLP. In the main management, Prakash M Patil is chairman and is the company secretary for Aarti Drugs Ltd.

  • PMP Prakash M Patil CMD & Executive Director
  • RCG Rashesh C Gogri ED / MD / Promoter
  • HMS Harshit M Savla ED / Joint MD / Promoter
  • HPS Harit P Shah E D & Wholetime Director
  • UMP Uday M Patil WTD & Executive Director
  • NJS Narendra Jagannath Salvi Non Executive Director
  • NCS Navin Chapshi Shah Independent Non Exe. Director
  • KGA Krishnacharya G Akamanchi Independent Non Exe. Director
  • PS Priti Savla Independent Non Exe. Director
  • AVP Ankit Vikram Paleja Independent Non Exe. Director
  • BNT Bhaskar Narayan Thorat Independent Non Exe. Director
  • NG Neha Gada Independent Non Exe. Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement